Winter 2020
An on-line talk to PCaSO by Timon Colegrove, 6th October 2020
Timon Colegrove’s experience is quite rare, in that following his diagnosis with prostate cancer in 2017, as an otherwise fit and healthy man in his mid 50’s, he has undergone Proton Beam Therapy (PBT). He is now sharing his experience with prostate cancer groups throughout the country, raising awareness of the benefits of this new treatment (which is not yet available on the NHS for prostate cancer patients). He summarises the last few years as a journey through diagnosis, dilemma, luck, decisions, treatment and outcomes.
Timon has a twitter channel @TimonColgrove, and a Google search of his name produces a variety of articles.
Under the NHS, there is currently only one PBT machine in the UK, at Christie Hospital, Manchester. A second machine is due to open in London at UCLH soon.
Timon had first heard of PBT in 2014 when the news media highlighted the plight of a young boy with a brain tumour, whose parents took him abroad for proton beam treatment, contrary to NHS advice. The youngster is now a cancer-free healthy 11 year old.
In 2017 Timon had a general medical test, at a time of career change. His PSA came out at 5.2, being slightly higher than the norm of 4.0 for his age group. He had no symptoms. His local hospital in Oxford said “Probably nothing but we’ll do a scan”. This showed a few unidentified shadows. “Probably nothing but we’ll do a biopsy”. The ensuing transperineal biopsy did lead to alarming [but not abnormal] blood loss and 3 weeks of discomfort.
After his cancer diagnosis was confirmed, Timon was offered a choice of radical prostatectomy (40% chance of lasting nerve damage), or brachytherapy (40% chance of incontinence and/or impotence). This left him frightened, confused and bemused.
Timon shared his experience with a friend in a similar situation. Prostate cancer was understood to affect 1 man in 8, but 1 in 4 if the father had the disease (as had Timon’s own father in his mid 90’s). He went to a local prostate cancer support group’s meeting, where he was welcomed and learned a lot from others. PBT was referenced as using extremely accurate laser light, which resulted in much less damage to the surrounding healthy tissue. However his hospital consultant dismissed PBT with “There isn’t the data to support the use of PBT”. This was very deflating! However his oncologist, who was looking to study PBT, provided him with a glimmer of hope.
Timon’s scans were sent to the Rutherford Cancer Centre, which is a private medical company with two proton beam centres, one in Newport, South Wales and another recently opened in Thames Valley, Reading. Timon was accepted as a patient and treatment started by reducing the size of his prostate with hormone therapy, with associated side effects such as loss of libido. Prior to the PBT, a gel spacer was inserted between his prostate and rectum, to minimise the risk of damage to the latter. Timon then had 20 fractions of PBT at the Rutherford Centre in South Wales over the course of a month. The only noticeable side effect was the need to pass water more frequently, but this only lasted 3 weeks.
Timon’s PSA is now an admirably low 0.02.
PBT machines are incredibly expensive high tech equipment. The Christie and intended London sites are primarily directed to children’s cancers, and adult ‘difficult to reach’ cancers. PBT is not intended for prostate cancer because other treatments are available, albeit at greater risk of side effects and impact upon quality of life. More patients can now be handled by PBT using only 10 sessions at double strength rather than 20.
Treatment by PBT for prostate cancer is not available on the NHS, and to go private is likely to cost ‘the same as a new family-size car’. Private health insurers are unlikely to fund PBT, due to the availability of other remedies and the NHS line that there is ‘not sufficient data for PBT’.
Timon answered questions from participants in the zoom meeting, advising that his treatment was for the prostate itself, there was no metastatic cancer. Also it is not known if any tissue scarring occurs that would preclude future treatment (as can happen with radiotherapy). Interestingly Timon had recently spoken with his GP who admitted to seeing many prostate cancer patients with side effects from ‘traditional radiotherapy. Only time will tell whether Timon’s treatment is 100% successful, there will need to be conclusive evidence from clinical trials before PBT is available on the NHS for prostate patients.
Timon was thanked for giving his time for this very interesting and useful talk. Participants acknowledged his clear content, and delivery style.
Notes by Lance Allen.
First published in PCaSO Updates 70
There are numbers you can call and support groups you can join if you want to talk to someone.
By volunteering with us, you can help raise awareness, support fundraising events, and provide vital assistance. Whether you have a few hours to spare or want to get involved long-term, your time and energy can make a real difference.
Membership of PCaSO is free for both yourself and your spouse or partner. Get updates about PCaSO activities and things that are happening in the wider world of prostate cancer.